Cantor Fitzgerald’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,897,500
Closed -$142K 382
2024
Q4
$142K Buy
+1,897,500
New +$22M ﹤0.01% 201
2023
Q3
Sell
-1,875,000
Closed -$20M 614
2023
Q2
$20M Hold
1,875,000
0.46% 78
2023
Q1
$19.7M Hold
1,875,000
0.42% 75
2022
Q4
$19.2M Hold
1,875,000
0.41% 69
2022
Q3
$18.9M Buy
+1,875,000
New +$18.8M 0.41% 57

Other funds holding RENE

Cantor Fitzgerald's RENE Position: Q1 2025 in Review

Cantor Fitzgerald sold out of Cartesian Growth Corp II (RENE) in Q1 2025, closing a stake of 1,897,500 shares — an estimated $142K sold.

Cantor Fitzgerald first reported a position in RENE in Q3 2022 and held it in 5 quarters. The position peaked at $20M in Q2 2023. 17 funds tracked by Wall St. Rank hold RENE as of Q1 2025.

  • Cantor Fitzgerald reported no remaining Cartesian Growth Corp II position as of Q1 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 1,897,500 Cartesian Growth Corp II shares in Q1 2025, an estimated $142K.
  • Cantor Fitzgerald first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 5 quarters.
  • Cantor Fitzgerald's Cartesian Growth Corp II position peaked at $20M in Q2 2023.
  • 17 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2025.

Based on Cantor Fitzgerald's 13F filing for Q1 2025, filed 15 May 2025.